• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    JIN MEDICAL INTERNATIONAL LTD.'s New Ultralight Electric Wheelchairs and Electric Mobility Vehicles Win Top Industrial Design Awards in China

    6/16/23 8:00:00 AM ET
    $ZJYL
    Industrial Specialties
    Health Care
    Get the next $ZJYL alert in real time by email

    Changzhou City, China, June 16, 2023 (GLOBE NEWSWIRE) -- JIN MEDICAL INTERNATIONAL LTD. (the "Company" or "JinMed") (NASDAQ:ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced that the Company's new ultralight electric wheelchairs and electric mobility vehicles designed for the elderly and developed in collaboration with Nanjing Tech University ("NJTech"), have both received the top awards at the 9th Zijin Award for Industrial Design Competition for their exceptional designs and engineering functionalities.

    The Zijin Award for Industrial Design Competition is a prestigious award in the field of industrial design in China, and is organized by the China Industrial Design Association. The award recognizes the outstanding contributions of companies and designers in product design, industrial design, brand design, packaging design, and exhibition design, etc.

    The judging panel evaluates the designs based on several criteria, including innovativeness, aesthetic appeal, practicality, and sustainability, while also considering their market applications.

    The Company's award-winning electric wheelchairs and electric mobility vehicles are expected to be ready for sale to the mass market this year.

    Mr. Erqi Wang, Chairman and CEO of the Company stated, "Winning the awards is a significant achievement, and we are honored to have our products recognized by the Zijin Award for Industrial Design Competition, which represents excellence in the field of industrial design. "

    "At JinMed we strive to design products that are both functional and aesthetically pleasing, and these awards validate our efforts. We will endeavor to continue to push the boundaries of innovation and design to create products that improve the quality of life for individuals with limited mobility."

    About Jin Medical International Ltd.

    Founded in 2006 and headquartered at Changzhou City, Jiangsu Province of China, the Company, through its Chinese operating entities, designs and manufactures wheelchairs and living aids products for people with disabilities, the elderly, and people recovering from injuries. The Company's Chinese operating entities operate 2 manufacturing plants with approximately 228,257 square feet in the aggregate in Changzhou City and Taizhou City, Jiangsu Province, China. The Company's Chinese operating entities have established relationships with over 40 distributors in China, and over 20 in the other regions of the world where it currently sells the products. The majority of the Company's wheelchair products, with more than 30 models, are sold to dealers in Japan and China, including Nissin Medical Industries Co., Ltd, one of the largest medical device distributors in Japan. The Company's Chinese operating entities own 106 patents and are in the process of registering 22 additional patents with the Patent Administration Department of the People's Republic of China and continuously deliver innovative wheelchair designs that are both lightweight and ergonomic each year. For more information, please visit: http://www.zhjmedical.com.

    Forward-Looking Statement

    This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performances, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not limited to, the following: the Company's ability to achieve its goals and strategies, the Company's future business development and plans for future business development, including its financial conditions and results of operations, product and service demand and acceptance, reputation and brand, the impact of competition and pricing, changes in technology, government regulations, fluctuations in general economic and business conditions, and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission ("SEC"). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, as well as its current reports on Form 6-K and other filings, all of which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

    For more information, please contact:

    Investor Relations

    Wealth Financial Services LLC

    Janice Wang

    Email: services@wealthfsllc.com

    Phone: +86 13811768599

    +1 628 283 9214



    Primary Logo

    Get the next $ZJYL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ZJYL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ZJYL
    SEC Filings

    View All

    SEC Form 6-K filed by JIN MEDICAL INTERNATIONAL LTD.

    6-K - Jin Medical International Ltd. (0001837821) (Filer)

    4/7/26 4:30:01 PM ET
    $ZJYL
    Industrial Specialties
    Health Care

    SEC Form 6-K filed by JIN MEDICAL INTERNATIONAL LTD.

    6-K - Jin Medical International Ltd. (0001837821) (Filer)

    3/17/26 4:30:16 PM ET
    $ZJYL
    Industrial Specialties
    Health Care

    SEC Form 20-F filed by JIN MEDICAL INTERNATIONAL LTD.

    20-F - Jin Medical International Ltd. (0001837821) (Filer)

    2/9/26 8:55:46 PM ET
    $ZJYL
    Industrial Specialties
    Health Care

    $ZJYL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement

    CHANGZHOU, China, April 7, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment, today announced that it has received written notification from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement. The Company regained compliance after its Class A ordinary shares maintained a closing bid price of at least $1.00 per share for more than ten (10) consecutive business days.T

    4/7/26 7:00:00 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    Jin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance Initiative

    CHANGZHOU, China, March 11, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment, today announced that its Board of Directors has approved an 1-for-20 share combination of all its authorized and issued ordinary shares (the "Stock Combination") pursuant to the authorization granted from an extraordinary general meeting of the Company's shareholders on January 30, 2026 (the "EGM"). Effective as of the date of the EGM, the Company's authorized share capital is reclassified into a dual class of Class A ordinary shares

    3/11/26 7:30:00 PM ET
    $ZJYL
    Industrial Specialties
    Health Care

    Jin Medical CEO Fireside Chat

    CHANGZHOU, China, Feb. 5, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment hosted a CEO Fireside Chat on February 2, 2026 where the CEO shared some insights into the Company's recent strategic priorities and long-term growth considerations. The following questions were prepared by the Company and addressed by the Company's CEO, Dr. Erqi Wang during the conversation. Certain statements made during the discussion were forward-looking, and the Company provided a cautionary note regarding forward-looking statements prior to the start of th

    2/5/26 8:57:00 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    $ZJYL
    Financials

    Live finance-specific insights

    View All

    Jin Medical International Limited (NASDAQ: ZJYL) Announces Financial Results for Six Months Ended March 31, 2023

    CHANGZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Jin Medical International Limited ("the Company" or "JinMed") (NASDAQ:ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced its financial results for the six months ended March 31, 2023 ("the period"). Financial and Operational Highlights for Six Months Ended March 31, 2023 Revenues were $10.25 million, representing an 8.3% increase from $9.47 million for the first six months ended March 31, 2022.Revenues from wheelchair products were $8.38 million, an increase of 5.4% from $7.95 million for the six months ended March 31, 2022.Revenues from whee

    8/23/23 4:15:00 PM ET
    $ZJYL
    Industrial Specialties
    Health Care